- •
A strong scientific rationale exists for providing pulmonary rehabilitation (PR) to persons with many forms of respiratory disease other than chronic obstructive pulmonary disease.
- •
Nearly all published clinical trials have shown beneficial effects of PR for such patients.
- •
Evidence to date shows that PR for patients with disorders other than chronic obstructive pulmonary disease is feasible, safe, and effective.
- •
PR should be provided according to a disease-relevant approach to ensure patient safety
Pulmonary Rehabilitation for Respiratory Disorders Other than Chronic Obstructive Pulmonary Disease
Section snippets
Key points
Rationale for PR in non-COPD disorders
The scientific rationale for PR for persons with COPD is that it can stabilize or reverse many systemic manifestations of the disease, including skeletal muscle dysfunction.4, 5 Participation in PR also improves exercise capacity, reduces knowledge deficits, promotes use of long-term health-enhancing behaviors, reduces depression and anxiety,6 helps patients manage complex medical regimens and exacerbations, reduces hospitalizations,7, 8 improves patients’ QOL,1, 9 and can improve physical
Asthma
Asthma affects all age groups and is a leading cause of chronic illness in children and adults. As a result of airflow obstruction, increased work of breathing and symptom exacerbation (including exercise-induced bronchoconstriction [EIB] for some persons), patients with asthma often experience dyspnea, show less tolerance for exercise despite optimized pharmacologic therapy, and have low physical activity levels.21, 22 Poor asthma control is associated with a greater prevalence of functional
ILD/Pulmonary Fibrosis
ILD (diffuse parenchymal lung disease) is a heterogeneous group of disorders in which the lung interstitium and/or alveolar spaces are involved with varying degrees (and differing histopathologic patterns) of inflammation or fibrosis. Typical symptoms of ILD include disabling exertional dyspnea,77, 78 nonproductive cough, and fatigue, and other symptoms may also be present when the ILD is part of a systemic disease.
Patients with ILD also have reduced exercise tolerance79 and low physical
Pulmonary Hypertension (PH)
PH, defined as an elevation in mean pulmonary artery pressure above 25 mm Hg at rest or higher than 30 mm Hg with exercise, arises from a wide variety of conditions.113 Pulmonary arterial hypertension (PAH) is a condition that results from structural remodeling of pulmonary arteries and endothelial dysfunction in the absence of underlying left-sided cardiac disease, parenchymal lung disease or direct involvement of the pulmonary venous circulation. Currently available pharmacologic therapies
Practical challenges of providing PR to persons with respiratory disorders other than COPD
Provision of PR to persons with disorders other than COPD poses several practical challenges. First, it requires PR care providers to be familiar with the anatomic, physiologic, and clinical features of, as well as treatment options for, these diverse disorders. This in turn poses the challenge of providing educational sessions and reading materials to and assessing competencies of staff members whose clinical experience may have been limited largely to caring for patients with COPD. Second,
Summary
PR is an important therapeutic intervention that should no longer be considered suitable only for patients with COPD. A strong rationale exists for providing PR to persons with a broad range of respiratory disorders other than COPD. Evidence shows that PR for these patients is feasible, safe, and effective. A disease-relevant approach should be undertaken based on individuals' needs. Further research is needed to better understand the optimal program content, duration, and outcomes measures, to
References (190)
- et al.
Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines
Chest
(2007) - et al.
Quadriceps weakness is related to exercise capacity in idiopathic pulmonary fibrosis
Chest
(2005) - et al.
Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation
Respir Med
(2005) - et al.
Physical activity, lung function, and shortness of breath in the daily life of individuals with asthma
Chest
(2010) - et al.
Impact of asthma control on sleep, attendance at work, normal activities and disease burden
Ann Allergy Asthma Immunol
(2010) - et al.
High-intensity physical training in adults with asthma: a 10-week rehabilitation program
Chest
(1996) - et al.
Effects of aerobic training on psychosocial morbidity and symptoms in patients with asthma
Chest
(2010) - et al.
Emotional quality-of-life and outcomes in adolescents with asthma
J Pediatr
(2004) - et al.
Bone health, daily physical activity, and exercise tolerance in patients with cystic fibrosis
Chest
(2011) - et al.
Reduced physical activity associated with work and transport in adults with cystic fibrosis
J Cyst Fibros
(2013)
Work disability in adults with cystic fibrosis and its relationship to quality of life
J Cyst Fibros
A randomized controlled trial of a 3 year home exercise program in cystic fibrosis
J Pediatr
Effects of anaerobic training in children with cystic fibrosis
Chest
Strength vs. aerobic training in children with cystic fibrosis: a randomized controlled trial
Chest
Variable weight training in cystic fibrosis
Chest
Exercise and physical activity in children with cystic fibrosis
Paediatr Respir Rev
Inspiratory muscle training in patients with cystic fibrosis
Respir Med
Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis
Chest
Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis
Chest
Aerobic exercise and respiratory muscle strength in patients with cystic fibrosis
Respir Med
Exercise improves lung function and habitual activity in children with cystic fibrosis
J Cyst Fibros
Effects of exercise on respiratory flow and sputum properties in patients with cystic fibrosis
Chest
Benefits of neuromuscular electrical stimulation prior to endurance training in patients with cystic fibrosis and severe pulmonary dysfunction
Chest
Interval training in cystic fibrosis–effect on exercise capacity in severely affected adults
J Cyst Fibros
Clinical determinants of the 6 minute walk test in bronchiectasis
Respir Med
Development and validation of the cystic fibrosis questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis
Chest
A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis
Respir Med
Depression and functional status are strongly associated with dyspnea in interstitial lung disease
Chest
Determinants of physical activity in daily life in candidates for lung transplantation
Respir Med
Effects of pulmonary rehabilitation in patients with restrictive lung diseases
Chest
Quadriceps weakness contributes to exercise capacity in nonspecific interstitial pneumonia
Respir Med
Assessment of health-related quality of life in patients with interstitial lung disease
Chest
Patient experiences with pulmonary fibrosis
Respir Med
Pulmonary rehabilitation for interstitial lung disease
Chest
Predictors of benefit following pulmonary rehabilitation for interstitial lung disease
Respir Med
Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response
Chest
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation
Am J Respir Crit Care Med
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management
Am J Respir Crit Care Med
Guidelines for the diagnosis and treatment of pulmonary hypertension
Eur Heart J
American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation
Am J Respir Crit Care Med
Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society
Am J Respir Crit Care Med
Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD
Am J Phys Med Rehabil
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
Cochrane Database Syst Rev
Outpatient pulmonary rehabilitation following acute exacerbations of COPD
Thorax
Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension
Thorax
Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis
Eur Respir J
Cystic fibrosis transmembrane conductance regulator in human muscle: dysfunction causes abnormal metabolic recovery in exercise
Ann Neurol
Physical activity among lung cancer survivors: changes across the cancer trajectory and associations with quality of life
Cancer Epidemiol Biomarkers Prev
The prognostic value of exercise testing in patients with cystic fibrosis
N Engl J Med
Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing
Circulation
Cited by (63)
Peak Quadriceps Muscle Torque and Electromyographic Output in Patients With Chronic Respiratory Disorders: Effects of Pulmonary Rehabilitation
2023, Archives of Rehabilitation Research and Clinical TranslationShort-Term Health Outcomes of a Structured Pulmonary Rehabilitation Program Implemented Within Rural Canadian Sites Compared With an Established Urban Site: A Pre-Post Intervention Observational Study
2023, Archives of Physical Medicine and RehabilitationPhysiotherapy management of interstitial lung disease
2022, Journal of PhysiotherapyCitation Excerpt :There is some evidence that candidates who underwent rehabilitation had improvements in 6MWD and health-related quality of life, as well as reduced hospital length of stay and improved survival following transplantation in patients with IPF;50 however, this is largely from uncontrolled studies. Rehabilitation also provides an opportunity for pre-transplant education, including preparation for the perioperative period (secretion management, controlled coughing, pain management, importance of early mobilisation) and optimisation of disease management (oxygen therapy, pacing, energy conservation, regular exercise).51 During the acute inpatient phase following transplantation, physiotherapy management (in intensive care and on the ward) comprises respiratory management, including airway clearance and oxygen titration, early mobility, exercise training and education.52
Respiratory management in daily life: Needs and gaps
2022, Wearable Sensing and Intelligent Data Analysis for Respiratory ManagementTelemedicine in Lung Cancer Rehabilitation
2022, Lung Cancer RehabilitationPulmonary Rehabilitation in ILD patients, a comprehensive intervention
2021, Open Respiratory Archives